Clinical Trial Update: Liposomal Vincristine Plus Dexamethasone in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating liposomal vincristine plus dexamethasone in relapsed or refractory acute lymphoblastic leukemia; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Liposomal vincristine (vincristine liposome)

Snippet

Sponsor: Acrotech Biopharma Inc. | Conditions: Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-01-18